| [1] |
Limper M, de Leeuw K, Lely AT, et al. Diagnosing and treating antiphospholipid syndrome: a consensus paper[J]. Neth J Med, 2019, 77(3): 98－108.
|
| [2] |
Coniglio M, Platania A, Di－Nucci GD, et al. Antiphospholipid－protein antibodies are not an uncommon feature in retinal venous occlusions[J]. Thromb Res, 1996, 83(2): 183－188 .
|
| [3] |
戴艳丽，魏世辉，黄厚斌. 抗磷脂抗体与视网膜静脉阻塞相关性的荟萃分析[J]. 中华眼底病杂志，2013，29(2)：188－192.
|
| [4] |
Houghton DE, Moll S. Antiphospholipid antibodies[J]. Vasc Med, 2017, 22(6): 545－550.
|
| [5] |
徐敏倩，罗晓红. 抗磷脂抗体综合征相关性复发性流产的研究进展[J]．中国医药科学，2021, 11(10)：45－48，64.
|
| [6] |
Yehudai D, Shoenfeld Y, Toubi E. Looking into the eyes of patients with antiphospholipid syndrome[J]. Clin Rev Allergy Immunol, 2007, 32(2): 192－197.
|
| [7] |
徐秋霞，王松，赵永志，等 .血栓栓塞性疾病[M]. 北京：中国医药科技出版社，2004：506－507.
|
| [8] |
林松波，陈韵蕉，郑悦，等 .血栓·抗凝·溶栓[M]. 福州：福建科学技术出版社出版，1999：103－104.
|
| [9] |
Modrzejewska M, Michalak A, Szmigiel O, et al. Ocular manifestations in a newborn from a pregnancy complicated by an antiphospholipid syndrome——a case report[J]. Ginekol Pol, 2013, 84(10): 888－891.
|
| [10] |
Storey P, Ter－Zakarian A, Rao N, et al. Severe bilateral retinal vascular occlusion as first presentation of systemic lupus erythematosus and antiphospholipid syndrome[J]. Retin Cases Brief Rep, 2017, 11(S1): S44－S48.
|
| [11] |
Ang LP, Lim AT, Yap EY. Central retinal vein and ophthalmic artery occlusion in primary antiphospholipid syndrome[J]. Eye (Lond), 2004, 18(4): 439－440.
|
| [12] |
Castañón C, Amigo MC, Bañales JL, et al. Ocular vaso－occlusive disease in primary antiphospholipid syndrome[J]. Ophthalmology, 1995, 102(2): 256－262.
|
| [13] |
Kleiner RC, Najarian LV, Schatten S, et al. Vaso－occlusive retinopathy associated with antiphospholipid antibodies (lupus anticoagulant retinopathy)[J]. Ophthalmology, 1989, 96(6): 896－904.
|
| [14] |
Asherson RA, Khamashta MA, Gil A, et al. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus－like disease, and the primary antiphospholipid syndrome[J]. Am J Med, 1989, 86(4): 391－399.
|
| [15] |
Ali O, Slagle WS, Hamp AM. Case report: branch retinal vein occlusion and primary antiphospholipid syndrome[J]. Optometry. 2011, 82(7): 428－433.
|
| [16] |
Korematsu S, Goto H, Gotoh C, et al. Central retinal vein occlusion in a pediatric patient with SLE and antiphospholipid antibodies without anti－cardiolipin or anti－β2 glycoprotein I antibodies[J]. BMC Pediatr, 2014, 14: 116.
|
| [17] |
Paccalin M, Manic H, Bouche G, et al. Antiphospholipid syndrome in patients with retinal venous occlusion[J]. Thromb Res, 2006, 117(4): 365－369.
|
| [18] |
宋佳，孙淑艳．非诊断标准抗磷脂抗体的研究进展[J]．中国实验诊断学，2020，24(4)：694－697.
|
| [19] |
Giordano N, Senesi M, Battisti E, et al. Antiphospholipid antibodies in patients with retinal vascular occlusions[J]. Acta Ophthalmol Scand, 1998, 76(1): 128－129.
|
| [20] |
Hartnett ME, Laposata M, van－Cott E. Antiphospholipid antibody syndrome in a six－year－old female patient[J]. Am J Ophthalmol, 2003, 135(4): 542－544.
|
| [21] |
Miserocchi E, Baltatzis S, Foster CS. Ocular features associated with anticardiolipin antibodies: a descriptive study[J]. Am J Ophthalmol, 2001, 131(4): 451－456.
|
| [22] |
Suvajac G, Stojanovich L, Milenkovich S. Ocular manifestations in antiphospholipid syndrome[J]. Autoimmun Rev, 2007, 6(6): 409－414.
|
| [23] |
Ben－Brahim M, Arfa S, Boubaker F, et al. Case Report: Recurrent retinal vein occlusion as the first clinical manifestation of systemic lupus erythematosus in a male patient[J]. F1000Res, 2021, 10: 761.
|
| [24] |
Demirci FY, Küçükkaya R, Akarçay K, et al. Ocular involvement in primary antiphospholipid syndrome: Ocular involvement in primary APS[J]. Int Ophthalmol, 1998, 22(6): 323－329.
|
| [25] |
Abegg M, Tappeiner C, Wolf－Schnurrbusch U, et al. Treatment of branch retinal vein occlusion induced macular edema with bevacizumab[J]. BMC Ophthalmol, 2008, 8: 18.
|
| [26] |
Cekiç O, Chang S, Tseng JJ, et al. Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion[J]. Retina, 2005, 25(7): 851－855.
|
| [27] |
Chaturvedi S, McCrae KR. Diagnosis and management of the antiphospholipid syndrome[J]. Blood Rev, 2017, 31(6): 406－417.
|
| [28] |
Agarwal M, Biswas J. Central retinal vein occlusion in primary antiphospholipid antibody syndrome[J]. Retin Cases Brief Rep, 2009, 3(3): 293－295.
|
| [29] |
Kent D, Hickey－Dwyer M, Clark D. Long－term follow－up of ischaemic retinopathy in the antiphospholipid syndrome with lupus－like disease[J]. Eye, 2000, 14(3): 313－317.
|
| [30] |
Querques L, Terrada C, Souied EH, et al. Bilateral sequential central retinal vein occlusion associated with primary antiphospholipid syndrome[J]. J Fr Ophtalmol, 2012, 35(6): 443.
|
| [31] |
Wiechens B, Schröder JO, Pötzsch B, et al. Primary antiphospholipid antibody syndrome and retinal occlusive vasculopathy[J]. Am J Ophthalmol, 1997, 123(6): 848－850.
|
| [32] |
Gelman R, Tsang SH. Sequential central retinal vein and ophthalmic artery occlusions in a pediatric case of primary antiphospholipid syndrome[J]. Retin Cases Brief Rep, 2016, 10(1): 58－62.
|
| [33] |
Asherson RA, Cervera R, Piette JC, et al. Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients[J]. Medicine (Baltimore), 1998, 77(3): 195－207.
|
| [34] |
Trojet S, Loukil I, El－Afrit MA, et al. Bilateral retinal vascular occlusion during antiphospholipid antibody syndrome: a case report[J]. J Fr Ophtalmol, 2005, 28(5): 503－507.
|
| [35] |
中华医学会风湿病学分会. 抗磷脂综合征诊断和治疗指南[J]．中华风湿病学杂志，2011，15(6)：407－410.
|
| [36] |
Au A, O′Day J. Review of severe vaso－occlusive retinopathy in systemic lupus erythematosus and the antiphospholipid syndrome: associations, visual outcomes, complications and treatment[J]. Clin Exp Ophthalmol, 2004, 32(1): 87－100.
|
| [37] |
Koch JW, al－Nawaiseh I, Koch FH. Severe occlusive bilateral retinal vasculitis within the scope of seronegative systemic lupus erythematosus[J]. Klin Monbl Augenheilkd, 1992, 201(5): 330－336.
|
| [38] |
Neumann R, Foster CS. Corticosteroid－sparing strategies in the treatment of retinal vasculitis in systemic lupus erythematosus[J]. Retina, 1995, 15(3): 201－212.
|
| [39] |
Snyers B, Lambert M, Hardy JP. Retinal and choroidal vaso－occlusive disease in systemic lupus erythematosus associated with antiphospholipid antibodies[J]. Retina, 1990, 10(4): 255－260.
|
| [40] |
Giorgi D, Pace F, Giorgi A, et al. Retinopathy in systemic lupus erythematosus: pathogenesis and approach to therapy[J]. Hum Immunol, 1999, 60(8): 688－696.
|
| [41] |
Glacet－Bernard A, Kuhn D, Vine AK, et al. Treatment of recent onset central retinal vein occlusion with intravitreal tissue plasminogen activator: a pilot study[J]. Br J Ophthalmol, 2000, 84(6): 609－613.
|
| [42] |
Moreno－Páramo D, Rayón－Rodríguez MA, García－Leonardo JI. Combined central retinal artery and vein occlusion; first manifestation of lupus in a pediatric patient[J]. Arch Soc Esp Oftalmol (Engl Ed), 2019, 94(3): 141－144.
|
| [43] |
Al－Latayfeh M, Silva PS, Sun JK, et al. Antiangiogenic therapy for ischemic retinopathies[J]. Cold Spring Harb Perspect Med, 2012, 2(6): a006411.
|
| [44] |
Fitzpatrick EP, Chesen N, Rahn EK. The lupus anticoagulant and retinal vaso－occlusive disease[J]. Ann Ophthalmol, 1990, 22(4): 148－152.
|
| [45] |
Hwang HS, Kang S. Combined central retinal vein and artery occlusion in systemic lupus erythematosus patient[J]. Retin Cases Brief Rep, 2012, 6(2): 187－188.
|
| [46] |
Parchand SM, Vijitha VS, Misra DP. Combined central retinal artery and vein occlusion in lupus[J]. BMJ Case Rep, 2017: 218848.
|
| [47] |
Lu BW, Xie LK, Hao XF, et al. Combined central retinal artery and vein occlusion associated with primary antiphospholipid syndrome treated by injection of dexamethasone intravitreal implant and anticoagulant therapy: a case report[J]. Int J Ophthalmol, 2022, 15(6): 1027－1029.
|
| [48] |
Cekiç O, Chang S, Tseng JJ, et al. Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion[J]. Retina, 2005, 25(7): 851－855.
|
| [49] |
Joäo MD, Costa JV, Santos GC, et al. Retinal vein and artery occlusion as the first manifestation of primary antiphospholipid syndrome in a pediatric patient [J]. Arq Bras Oftalmol, 2022: 8207.
|